Literature DB >> 6833458

Prolactin response to dopamine synthesis inhibition using monoiodotyrosine in subjects on oral contraceptives and patients with pathological hyperprolactinemia.

K Y Ho, G A Smythe, L Lazarus.   

Abstract

Entities:  

Keywords:  Amenorrhea; Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Methods; Diseases; Drugs--administraction and dosage; Drugs--pharmacodynamics; Endocrine System; Ethinyl Estradiol; Family Planning; Gonadotropins; Gonadotropins, Pituitary; Hormones; Menstruation; Menstruation Disorders; Oral Contraceptives; Oral Contraceptives, Combined; Physiology; Pituitary Hormones; Prolactin--analysis; Reproduction; Reproductive Control Agents; Treatment

Mesh：

Substances：

Year:  1983        PMID： 6833458     DOI： 10.1210/jcem-56-4-692

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  3 in total

Review 1.  Hyperprolactinemia: neuroendocrine and diagnostic aspects.

Authors:  F Camanni; E Ciccarelli; E Ghigo; E E Müller
Journal:  J Endocrinol Invest       Date:  1989-10       Impact factor: 4.256

Review 2.  Therapeutic applications of bromocriptine in endocrine and neurological diseases.

Authors:  K Y Ho; M O Thorner
Journal:  Drugs       Date:  1988-07       Impact factor: 9.546

3.  Prolactin and thyrotropin response to blockade of dopamine synthesis by monoiodotyrosine in subjects with postpartum and pathological hyperprolactinemia.

Authors:  E Ghigo; E Ciccarelli; A Novelli; M Massobrio; E E Müller; F Camanni
Journal:  J Endocrinol Invest       Date:  1985-02       Impact factor: 4.256
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.